Genetic Link Between Cannabis Use and Psychosis Could Help Identify Those at Risk — Study
Researchers say it could help identify those most at risk of developing psychosis.
24 results for “psychosis”
Researchers say it could help identify those most at risk of developing psychosis.
Researchers found no short-term increase in health service use or frequency of psychotic disorders.
The authors say those who used cannabis had higher neurocognition and social functioning over time.
Researchers found no association between more potent cannabis and an increased risk of dependence or psychosis-like symptoms.
Three experts unpick what we really know – and what we don’t.
Researchers say their findings contrast with data suggesting cannabis use increases the risk of developing psychotic disorder.
Researchers at Oxford University have received a multi-million pound grant to carry out the study.
Researchers found no significant increase in the rates of psychosis-related diagnoses in states which have introduced legalisation.
Dr Di Forti explains the motivations behind a new study hoping to explore the effects of cannabis on the brain.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
Findings highlighting the relationship between trauma, THC and paranoia have prompted calls for improved patient monitoring.
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
Ministers raised concerns related to the growing use among young people and potential risks to mental health.
New research sheds light on the impact of cannabis legalisation on prescription drug claims following their implementation in the US. Approval of recreational and medical cannabis laws in most US […]
Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the 1971 Convention. After over […]
The authors of a new Canadian study have called for increased public funding to protect the ‘scientific integrity’ of cannabis research and reduce reliance on industry sponsorship. Research led by […]
The CRDG will set out the country’s first comprehensive strategy for cannabinoid research and development.
Researchers at LVR University Hospital Essen in Germany have announced the results of a new study on the efficacy of medical cannabis in treating chronic depression. According to the findings, […]
The study is the first to explore how genetic differences affect individual responses to THC.
Researchers say the treatment also has significantly fewer side-effects than conventional medicines.
The UK saw the second highest number of clinical trials on cannabinoids in the last decade, the majority linked to GW Pharmaceuticals.
The annual European Drug Report gives an overview of the key trends in drug use across the EU.
Neither current, nor lifetime cannabis use was associated with an increased risk of developing the condition.